Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 27 for “"p-mTOR"”.
-
Εκτίμηση της προβλεπτικής και προγνωστικής σημασίας του mTOR (mammalian Target Of Rapamycin) σε ασθενείς με καρκίνο του μαστού
… the prognostic/predictive value of p-Akt and p-mTOR protein expression in patients with high-risk early breast cancer. Formalin-fixed paraffin-embedded (FFPE) tumor tissue samples from 997 patients participating in two adjuvant chemotherapy phase III trials were assessed by immunohistochemistry …
-
Μελέτη των σηματοδοτικών οδών BRAF/MEK/ERK και AKT/mTOR στη λευχαιμία εκ τριχωτών κυττάρων
… Hairy Cell Leukemia (HCL) lymphomagenesis. ΑΚΤ/mTOR pathway plays critical role in cell proliferation, differentiation and migration and is interconnected with MAPK signalling in several points. This study investigates for the first time the potential ΑΚΤ/mTOR pathway activation in HCL and its …
-
Μελέτη του ρόλου του σηματοδοτικού μονοπατιού του m-TOR σε σχέση με τη λεμφαγγειογένεση στο αδενοκαρκίνωμα του προστάτη
… conserved mammalian target of rapamycin (mTOR) is a serine/threonine kinase of the phosphatidylinositol 3-kinase (PI3K)/AKT signaling pathway. Many studies suggest a role of m-TOR in angiogenesis via the upregulation of VEGF-A. In lymphangiogenesis the participation of mTOR is more …
-
Immunhistochemische Analyse der Expression von mTOR-Pfadweg-Komponenten in Neuroendokrinen Tumoren des Magens
Background: The mammalian target of rapamycin (mTOR) is an important regulator of cell proliferation and protein translation and is activated in various malignancies. Expression of mTOR cascade components in gastric neuroendocrine tumors (NETs), however, has not yet been fully explored. Aims: The …
-
Ανοσοϊστοχημική διερεύνηση ενδοκυττάριων οδών σηματοδότησης σε καρκινώματα ενδομητρίου και μη νεοπλασματικό ενδομήτριο
Background/Aim: The Akt/mTOR and MAPK pathways are frequently activated in various tumor types but data on endometrial carcinoma are limited. The aim of this study was to investigate the clinical significance of the expression of phosphorylated MAPK, Akt and mTOR (p-MAPK, p-Akt, p-mTOR) in type I …
-
Estudio de la ruta de señalización celular de PI3K-AKT-mTOR en los carcinomas epidermoides nasosinusales
… tumores de mal pronóstico. La ruta de PI3K/AKT/mTOR es la vía oncogénica mutada más frecuente en carcinomas escamosos de cabeza y cuello (CECC). El papel de la vía PI3K/AKT/mTOR y su implicación clínica y pronóstica en CENS todavía no ha sido investigada. El objetivo de este estudio fue evaluar …
-
Μελέτη των προτύπων ενεργοποίησης του πλακουντιακού mtor σε εγκυμοσύνες με σακχαρώδη διαβήτη κύησης
Σκοποί Η πρωτεΐνη mTOR είναι μια κινάση σερίνης που παίζει κυρίαρχο ρόλο ως κεντρικός ρυθμιστής της κυτταρικής ανάπτυξης, του πολλαπλασιασμού και της επιβίωσης αλληλεπιδρώντας με ποικίλες πρωτεΐνες, διαδραματίζοντας σημαντικό ρόλο στη διαδικασία της γήρανσης καθώς και στην εμφάνιση και την εξέλιξη …
-
Εφαρμογή των μεθόδων μοριακής βιολογίας για την μελέτη μεταγωγής σήματος στον καρκίνο του οισοφάγου
… prognostic significance of MAPK and PI3K-AKT-mTOR pathways in human esophageal carcinogenesis.Methods: We searched for mutations in EGFR, KRAS, B-RAF, PIK3CA and AKT-1 genes by High Resolution Melting Analysis (HRMA) and Pyrosequencing in 44 esophageal carcinomas. Immunohistochemistry was …
-
Μελέτη της οδού μεταγωγής σήματος του επιδερμικού αυξητικού παράγοντα σε ασθενείς με βασικού τύπου καρκίνου του μαστού
… we evaluate the expression of EGFR/PI3K/AKT/mTOR pathway in combination with PTEN in the subgroup of patients with triple negative (ΤΝ) immunophenotype. One hundred thirty one patients with operable high risk breast cancer, received additional intensive sequential chemotherapy with or without …
-
Μη μικροκυτταρικός καρκίνος του πνεύμονα και μονοπάτι PI3K
… homolog (AKT)/mammalian target of rapamycin (mTOR) pathway is upregulated in a number of human cancers, including non-small cell lung cancer (NSCLC). Its potential role in NSCLC progression provides an attractive target for anticancer therapy. The expression of phosphorylated mTOR (p-mTOR), …
-
RHABDOMYOSARCOMA 2 ASSOCIATED TRANSCRIPT (RMST) AS A NEGATIVE REGULATOR OF MAMMALIAN TARGET OF RAPAMYCIN (MTOR) IN CANCER CELLS
… and Immunohistochemistry study (to detect the p-mTOR levels in both cancer and normal prostate and colon human tissues) were performed and then their levels were compared in both the normal and cancer human prostate and colon tissue studied.The lovastatin treatment has cytotoxic effects in …
-
Η επίδραση μεταβολικών διαταραχών στην καρδιακή αναδιαμόρφωση σε μοντέλο πειραματικού εμφράγματος μυοκαρδίου σε επίμυες
… ratios of phosphorylated (p)-Akt/total Akt and p-mTOR/total mTOR were increased 2.0 fold and 2.7 fold in DM-AMI + TH vs DM-AMI respectively, p < 0.05. Furthermore, the ratio of p-AMPK/total AMPK was found to be increased 1.6 fold in DM-AMI + TH vs DM-AMI, p < 0.05.Conclusion. TH treatment improved …
-
Ασκησιογενής μυϊκός τραυματισμός και οξειδωτικό στρές
… were measured. For transport pathways p-PKB, p-mTOR, p-p70S6k,MyoD, p38, p-NF-kB, p-rpS6, TNF-a were measured. Results: NAC changed muscleredox status protecting oxidative stress. Also NAC delayed the return of muscleperformance after eccentric exercise. A positive effect of NAC was the …
-
Investigation of the Effects of mTOR Inhibitors Rapamycin and Everolimus in Combination with Carboplatin on Canine Malignant Melanoma Cells.
… aggressive therapy. Upregulation of the PI3K/AKT/mTOR pathway has been observed in canine malignant melanoma and may represent a potential target for therapy. Rapamycin (sirolimus) and everolimus are commercially available small molecule inhibitors that target mTOR; therefore, may have anticancer …
-
Gastrin-releasing peptide-mediated neuroblastoma growth: A role for the PI3K/Akt pathway
… inhibited the expressions of VEGF, p-Akt, and p-mTOR in vitro. GRPR knockdown induced cell morphology changes, reduced cell size, decreased cell proliferation, and inhibited DNA synthesis, which corresponded to G2/M cell cycle arrest. Activated Akt and its downstream regulators of protein …
-
The Effects of Neuromuscular Electrical Stimulation on Anabolic Signaling in Older Adults
… S6K1( p = 0.020) and phosphorylated mTOR (p = 0.009) had a significant main effect for time (S6K1 Day 1: Pre-NMES 0.65 ± 0.17, Post-30min 0.98 ± 0.17, Post-120min 1.01 ± 0.19; Post-Intervention: Day 12: PreNMES 0.63 ± 0.17, Post-30min 1.25 ± 0.17, Post-120min 0.89 ± 0.21) (mTOR Day 1: …
-
Skeletal muscle mitochondrial and inflammatory signaling in response to a single session of high-intensity interval exercise in hypoxia
… abundance, except for PGC-1α, p-AMPK and p-MTOR. Results from this study may help a better understanding of the molecular pathway as well as refine exericse protocols of HIIE in hypoxia to achieve a better outcome.
-
The Effect of Drugs of Abuse and HIV-1 GP120 on Autophagy in Astrocytes
… 1 receptor, and autophagy signaling proteins p-mTOR, Atg5, Atg7, and p-Bcl-2/Beclin-1 were determined by using selective inhibitors and siRNAs. In addition, we determined the role of autophagy in chronic cocaine exposure using MTT assay and western blot analysis. In the second chapter, the …
-
Analysis of MTORC2 in regulating aging, metabolism and cardiac disease in Drosophila melanogaster
… to improve cardiac health during aging. The MTOR (mechanistic target of rapamycin kinase) signaling, as a longevity pathway, is the master regulator of cellular homeostasis, metabolism, and longevity. MTOR signaling functions through two structurally and functionally distinct multiprotein …
-
EFFECTS OF INHIBITING THE MAMMALIAN TARGET OF RAPAMYCIN (MTOR) PATHWAY AND TELOMERASE IN BREAST CANCER CELLS
… explores the effects of rapamycin on the mTOR pathway and telomerase in breast cancer cells. The mTOR pathway, a prototypic survival pathway upregulated in many cancers, integrates various cellular signals serving as a master regulator of protein synthesis, ribosome biogenesis, autophagy, …
Page 1 of 2